In England cancer surveillance statistics are published
In England, cancer surveillance statistics L-Glutamine published on Public Health England’s ‘CancerData’ dashboard for each of the 209 local healthcare commissioning bodies (Clinical Commissioning Groups – CCGs) . These include the percentage of patients diagnosed with localised tumours (TNM Stage I/II), the percentage diagnosed following emergency admission or referral, and statistics on adherence to targets for patient waiting times.
Methods We conducted a systematic literature search to identify indicators of early cancer diagnosis in population-based data sources and evaluate their association with short-term mortality and survival. The association between each indicator and (i) risk of death within 30 days following diagnosis (“30-day mortality”) (ii) net survival at one and five years was then analysed for patients diagnosed in 2009–2013 in England with either colorectal cancer, non-small cell lung cancer (NSCLC) or ovarian cancer, malignancies frequently diagnosed at advanced stage .
Conflicts of interest
Acknowledgements PM and SW received funding from a Cancer Research UK Early Diagnosis Policy Research grant to the Cancer Policy Programme at the London School of Hygiene & Tropical Medicine (award number C7923/A18348), and LW is funded by a Cancer Research UK Population Research Postdoctoral Fellowship (award number C23409/A11415). The authors would like to thank members of the CRUK Scientific Advisory Group for their insights in the development medusa project. We additionally thank Public Health England for providing the data used in the data analysis, Aurelien Belot for statistical advice, Adrian Turculet for performing the data cleaning and linkage, and members of the LSHTM Cancer Survival Group for many informative discussions.
The authors regret that appeared incorrectly in this article, with columns 6 and 7 transposed. The authors would like to apologise for any inconvenience caused, and the table is reproduced correctly below.